Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.56 - $20.78 $935 - $1,433
69 Added 0.39%
17,724 $255,000
Q4 2023

Feb 13, 2024

SELL
$14.18 - $22.31 $1,006 - $1,584
-71 Reduced 0.4%
17,655 $379,000
Q3 2023

Nov 13, 2023

BUY
$18.22 - $25.85 $11,478 - $16,285
630 Added 3.69%
17,726 $340,000
Q2 2023

Aug 04, 2023

BUY
$22.62 - $39.32 $5,677 - $9,869
251 Added 1.49%
17,096 $434,000
Q1 2023

May 12, 2023

BUY
$30.17 - $41.11 $10,137 - $13,812
336 Added 2.04%
16,845 $608,000
Q4 2022

Feb 10, 2023

SELL
$36.43 - $49.4 $2,222 - $3,013
-61 Reduced 0.37%
16,509 $653,000
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $9,514 - $12,409
234 Added 1.43%
16,570 $772,000
Q2 2022

Aug 12, 2022

SELL
$40.85 - $77.67 $34,436 - $65,475
-843 Reduced 4.91%
16,336 $716,000
Q1 2022

May 13, 2022

SELL
$59.95 - $92.06 $72,419 - $111,208
-1,208 Reduced 6.57%
17,179 $1.24 Million
Q4 2021

Feb 11, 2022

SELL
$81.07 - $121.29 $44,588 - $66,709
-550 Reduced 2.9%
18,387 $1.49 Million
Q3 2021

Nov 12, 2021

SELL
$101.99 - $166.36 $45,997 - $75,028
-451 Reduced 2.33%
18,937 $2.2 Million
Q2 2021

Aug 13, 2021

SELL
$141.6 - $179.06 $61,029 - $77,174
-431 Reduced 2.17%
19,388 $3.21 Million
Q1 2021

May 07, 2021

BUY
$132.81 - $182.18 $7,038 - $9,655
53 Added 0.27%
19,819 $2.77 Million
Q4 2020

Feb 12, 2021

SELL
$138.17 - $184.34 $43,247 - $57,698
-313 Reduced 1.56%
19,766 $3.42 Million
Q3 2020

Nov 04, 2020

SELL
$114.09 - $145.51 $52,025 - $66,352
-456 Reduced 2.22%
20,079 $2.8 Million
Q2 2020

Aug 12, 2020

BUY
$89.45 - $129.85 $252,875 - $367,085
2,827 Added 15.96%
20,535 $2.45 Million
Q1 2020

May 04, 2020

SELL
$70.23 - $144.31 $71,775 - $147,484
-1,022 Reduced 5.46%
17,708 $1.77 Million
Q4 2019

Feb 05, 2020

SELL
$76.41 - $117.54 $11,996 - $18,453
-157 Reduced 0.83%
18,730 $2.2 Million
Q3 2019

Nov 08, 2019

BUY
$61.52 - $91.1 $5,598 - $8,290
91 Added 0.48%
18,887 $1.62 Million
Q2 2019

Aug 13, 2019

BUY
$58.04 - $66.99 $13,523 - $15,608
233 Added 1.26%
18,796 $1.22 Million
Q1 2019

May 06, 2019

SELL
$35.52 - $62.62 $21,383 - $37,697
-602 Reduced 3.14%
18,563 $1.16 Million
Q4 2018

Feb 13, 2019

SELL
$35.43 - $56.29 $5,243 - $8,330
-148 Reduced 0.77%
19,165 $745,000
Q3 2018

Nov 09, 2018

BUY
$44.22 - $75.47 $15,432 - $26,339
349 Added 1.84%
19,313 $1.1 Million
Q2 2018

Aug 08, 2018

BUY
$72.38 - $92.5 $75,854 - $96,940
1,048 Added 5.85%
18,964 $1.51 Million
Q1 2018

May 07, 2018

SELL
$69.46 - $88.57 $52,164 - $66,516
-751 Reduced 4.02%
17,916 $1.55 Million
Q4 2017

Feb 09, 2018

BUY
$65.94 - $93.31 $5,802 - $8,211
88 Added 0.47%
18,667 $1.29 Million
Q3 2017

Nov 09, 2017

BUY
$80.87 - $91.08 $1.5 Million - $1.69 Million
18,579
18,579 $1.69 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $116M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.